349 related articles for article (PubMed ID: 10913432)
1. Hyperlipidemia associated with the use of protease inhibitors.
Smith JH; Martin GJ; Decker CF
Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
[No Abstract] [Full Text] [Related]
2. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
Chang ES; Tetreault DD; Liu YT; Beall GN
J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
[No Abstract] [Full Text] [Related]
3. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released].
Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575
[No Abstract] [Full Text] [Related]
4. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
[No Abstract] [Full Text] [Related]
6. Using ritonavir with indinavir in cases of virologic failure.
TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
[No Abstract] [Full Text] [Related]
7. Ritonavir and indinavir one year later.
TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
[No Abstract] [Full Text] [Related]
8. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
[TBL] [Abstract][Full Text] [Related]
9. Kaletra versus nelfinavir.
TreatmentUpdate; 2001; 12(12):8-10. PubMed ID: 11570097
[No Abstract] [Full Text] [Related]
10. Risk factors for ritonavir intolerance and outcome after change to indinavir.
Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A
AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044
[No Abstract] [Full Text] [Related]
11. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
[TBL] [Abstract][Full Text] [Related]
12. A patient's guide to protease inhibitors.
Elperin A; Sax P
AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors and blood sugar problems.
TreatmentUpdate; 2001 Jun; 13(2):8. PubMed ID: 11570291
[No Abstract] [Full Text] [Related]
14. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
Klaus BD; Grodesky MJ
Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
[No Abstract] [Full Text] [Related]
15. HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications.
Kaul DR; Cinti SK; Carver PL; Kazanjian PH
Pharmacotherapy; 1999 Mar; 19(3):281-98. PubMed ID: 10221367
[TBL] [Abstract][Full Text] [Related]
16. The safety and antiviral effect of protease inhibitors in children.
Temple ME; Koranyi KI; Nahata MC
Pharmacotherapy; 2001 Mar; 21(3):287-94. PubMed ID: 11253853
[TBL] [Abstract][Full Text] [Related]
17. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
18. Effect of protease inhibitors on the sense of taste.
Schiffman SS; Zervakis J; Heffron S; Heald AE
Nutrition; 1999 Oct; 15(10):767-72. PubMed ID: 10501290
[TBL] [Abstract][Full Text] [Related]
19. Lipid lowering therapy in patients with HIV infection.
McBride M; Chin MT; Lee SM; Kelly B
Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
[No Abstract] [Full Text] [Related]
20. Development of HIV protease inhibitors: a survey.
Ren S; Lien EJ
Prog Drug Res; 1998; 51():1-31. PubMed ID: 9949858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
